Condition (MeSH)
Dementia, Multi-Infarct
ClinicalTrials.gov lists 6 trials for Dementia, Multi-Infarct or a narrower condition beneath it. MD Stem Cells has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
6 of the 6 trials are tagged with Dementia, Multi-Infarct itself; the rest are tagged with a narrower condition beneath it.
When did Dementia, Multi-Infarct trials start? (5)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 4
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2021 | 2 |
| 2020 | 1 |
| 2018 | 1 |
| 2014 | 1 |
| 1994 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Dementia, Multi-Infarct trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 4 | 1 |
| Not applicable | 4 |
| Observational | 1 |
How many Dementia, Multi-Infarct trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 3 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Dementia, Multi-Infarct trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| MD Stem Cells | 1 |
Which serious adverse events do Dementia, Multi-Infarct trials report? (1)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| natural disaster | 1 | 1 |
Which publications cover Dementia, Multi-Infarct? (16)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Acupuncture improved cognitive impairment caused by multi-infarct dementia in rats. | Physiology & behavior | 2005 | Yes |
| Cognitive impairment and functional outcome after stroke associated with small vessel disease. | Journal of neurology, neurosurgery, and psychiatry | 2004 | Yes |
| The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. | Brain : a journal of neurology | 2004 | Yes |
| Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. | Archives of neurology | 2004 | Yes |
| Cerebral microbleeds in CADASIL: a gradient-echo magnetic resonance imaging and autopsy study. | Stroke | 2002 | Yes |
Showing 5 of 16 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.